Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | VDR | P11473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30500515 | 1.00 | MEN1 (0.40) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL2387009 | 1.00 | MEN1 (0.40) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL2189297 | 0.84 | MEN1 (0.40) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL4789122 | 0.83 | MMP9 (0.37) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL10522629 | 0.83 | MMP9 (0.37) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL28722155 | 0.82 | MEN1 (0.39) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL2385785 | 0.81 | MEN1 (0.38) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL2385779 | 0.81 | MEN1 (0.38) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL2385783 | 0.81 | MEN1 (0.38) | MEN1KMT2ASTAT3CYP2D6CYP1A2 | |
| SCHEMBL4757045 | 0.79 | GAA (0.45) | MEN1KMT2ASTAT3CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116288767-A | High-elasticity high-temperature-resistant spandex fiber and preparation method thereof | 诸暨华海氨纶有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116288767-A | High-elasticity high-temperature-resistant spandex fiber and preparation method thereof | 诸暨华海氨纶有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116288767-A | High-elasticity high-temperature-resistant spandex fiber and preparation method thereof | 诸暨华海氨纶有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-8293715-B2 | 10a-Azalide compound crosslinked at 10a- and 12-positions | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2177526-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT POSITION-10A AND POSITION-12 | Taisho Pharmaceutical Co. Ltd. (JP) | 2010-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | DCLRE1A, AZI2, CHD9 | MEN1 3118/4885KMT2A 568/4885STAT3 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.